The Results of Nonoperative Treatment of Craniovertebral Junction Tuberculosis: A Review of Twenty-six Cases

Arora, Sumit; Sabat, Dhananjaya; Maini, Lalit; Sural, Sumit; Kumar, Vinod; Gautam, V. K.; Gupta, Ajay; Dhal, Anil
March 2011
Journal of Bone & Joint Surgery, American Volume;3/16/2011, Vol. 93-A Issue 6, p540
Academic Journal
Background: There is scarce information on craniovertebral junction tuberculosis even in developing countries. The pendulum of treatment in craniovertebral junction tuberculosis has periodically vacillated between nonoperative management and radical surgery. Methods: We performed a retrospective review of prospectively collected clinical and radiographic data on twenty-six consecutive patients with craniovertebral junction tuberculosis who were treated nonoperatively in our institution. The patients who had weakness of the limbs, pyramidal signs, or evidence of atlantoaxial dislocation and/or basilar invagination were immediately managed with immobilization with Crutchfield tongs traction (Group A), followed by halo-vest application. Patients without a neurological deficit, pyramidal signs, or atlantoaxial dislocation or basilar invagination were treated with cervical immobilization with early application of a halo vest (Group B). Results: The common presenting features were neck pain, restriction of neck movement, and spastic weakness of limbs. A retropharyngeal purulent fluid collection and osseous involvement of the dens and lateral mass of the atlas were the common radiographic findings. Twelve patients were partially or completely dependent on others for activities of daily living, and marked ligamentous and bone destruction with displacement at the atlantoaxial level was seen in eight patients at the time of presentation. The twenty patients in group A had cervical traction for a mean of 5.9 weeks, and a halo vest was applied for a mean of 6.9 months with antitubercular therapy for eighteen months. The mean follow-up period was 25.2 months (range, eighteen to forty-two months). All of the patients were independent in activities of daily living at the time of the last follow-up. Conclusions: In the Indian subcontinent, the disease process of craniovertebral junction tuberculosis is usually quite advanced at the time of presentation. On the basis of our study, patients with craniovertebral junction tuberculosis can be managed successfully with nonoperative treatment even with advanced involvement of bone or soft tissues at this spinal level.


Related Articles

  • A Retrospective Analysis of Isoniazid-Monoresistant Tuberculosis: Among Iranian Pulmonary Tuberculosis Patients. Varahram, Mohammad; Javad Nasiri, Mohammad; Farnia, Parissa; Mozafari, Mohadese; Akbar Velayati, Ali // Open Microbiology Journal;2014, Vol. 8, p1 

    Background and objectives: Isoniazid (INH) is one of the most potent anti-tuberculosis (TB) drugs. The spread and transmission of INH-resistant bacilli are likely to pose a significant problem for National TB control Program (NTP). In this study, we aimed to determine the trend of...

  • Endobronchial tuberculosis: Clinical and bronchoscopic features. Popevic, Spasoje; Markovic-Denic, Ljiljana; Skodric-Trifunovic, Vesna // HealthMed;2013, Vol. 7 Issue 2, p593 

    The aim: To determine the clinical and bronchoscopic features of EBTB in Serbia in eight-year period. Methods: Retrospective clinical study was conducted at the Institute for Lung Diseases and Tuberculosis, Clinical Center of Serbia. In the period from 01/02/1999. to 01/12/2007. all cases of...

  • Early descriptions of Grisel's syndrome. Golzari, Samad; Ghabili, Kamyar; Sajadi, Mohammad; Aslanabadi, Saeid // Child's Nervous System;Mar2013, Vol. 29 Issue 3, p359 

    A letter to the editor is presented in response to the article "Grisel's syndrome: a comprehensive review with focus on pathogenesis, natural history, and current treatment options," by S. Osiro, K. J. Tiwari, P. Matusz, J. Gielecki, R. S. Tubbs, and M. Loukas.

  • Combination TB drug approved.  // FDA Consumer;Sep94, Vol. 28 Issue 7, p2 

    Comments on approval by the Food and Drug Administration (FDA) of Rifater, a product that combines three existing tuberculosis drugs into a single tablet. Why this fixed-dose product was developed.

  • High prevalence of resistance to second-line anti-TB drugs.  // Reactions Weekly;9/8/2012, Issue 1418, p4 

    The article reports on the Preserving Effective TB Treatment Study (PETTS) which reveals that the prevalence of resistance to second-line antituberculosis drugs is high.

  • Are free anti-tuberculosis drugs enough? An empirical study from three cities in China. Shanquan Chen; Hui Zhang; Yao Pan; Qian Long; Li Xiang; Lan Yao; Lucas, Henry // Infectious Diseases of Poverty;10/28/2015, Vol. 4, p1 

    Background: Tuberculosis (TB) patients in China still face a number of barriers in seeking diagnosis and treatment. There is evidence that the economic burden on TB patients and their households discourages treatment compliance. Methods: A cross-sectional study was conducted in three cities of...

  • In vivo veritas: The search for TB drug targets goes live. McKinney, John D. // Nature Medicine;Dec2000, Vol. 6 Issue 12, p1330 

    The term 'microbial persistence' describes a phenomenon whereby microorganisms which are drug-susceptible when tested outside the body are nevertheless capable of surviving within the body despite intensive therapy with the appropriate antimicrobial drug. In clinical practice this phenomenon...

  • Ethambutol/isoniazid/pyrazinamide/rifampicin.  // Reactions Weekly;5/5/2012, Issue 1400, p20 

    The article describes the case of a patient who developed paradoxical worsening of cutaneous lesions after receiving antitubercular therapy for miliary tuberculosis.

  • Update on the Treatment of Tuberculosis. Inge, Lisa D.; Wilson, John W. // American Family Physician;8/15/2008, Vol. 78 Issue 4, p457 

    Approximately one third of the world's population, including more than 11 million persons in the United States, is latently infected with Mycobacterium tuberculosis. Although most cases of tuberculosis in the United States occur in foreign-born persons from endemic countries, the prevalence is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics